Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trial

DiscussionThe trial will establish whether the known benefits of intensive treatment strategies in active rheumatoid arthritis are also seen in patients with established rheumatoid arthritis who have moderately active disease. It will evaluate both the clinical and cost-effectiveness of intensive treatment.Trial registrationCurrent Controlled Trials, ID:ISRCTN70160382. Registered on 16 January 2014.
Source: Trials - Category: Research Source Type: clinical trials